Effects of exercise training and herbal medicine on inflammatory markers

Effects of high intensity interval training and ginger supplement on serum levels of soluble intracellular adhesion molecule type 1, monocyte chemotactic protein type 1, and interlukine 10 in overweight women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016051027836N1

Enrollment

Registered

2016-06-18

Start date

2016-06-30

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight. Simple obesity NOS

Interventions

Intervention 1: Train + Placebo Intervention Group: Doing high intensity interval training (40 meters maximal shuttle run, 4 repetitions in the first week and 8 repetitions in the 10th week, together

Prevention

Train + Placebo Intervention Group: Doing high intensity interval training (40 meters maximal shuttle run, 4 repetitions in the first week and 8 repetitions in the 10th week, together with daily intak

Ginger + Train Intervention group: Doing high intensity interval training (40 meters maximal shuttle run, 4 repetitions in the first week to 10 repetitions in the 10th week, together with daily intake

Ginger Group: Daily intake of 3 grams of Vomigan Ginger tablet produced in Dineh Company, Iran, 1 gram before each meal with 1 glass of water for 10 weeks without doing physical training

Eligibility

Sex/Gender

Female

Age

20 Years to 30 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Women aged between 20 to 30 years; having body mass index between 25 to 29.9 kilogram/squared meter Exclusion criteria: Having cardiovascular and respiratory problems; diabetes; high blood pressure; orthopedic diseases; smoking; pregnancy; regular exercise training during last year; having menstrual disorder

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Interlukine 10. Timepoint: 24 hours before the first session and 48 hours after the last training session at the end of 10 weeks of intervention. Method of measurement: Serum Blood Sampling, Special Kits.;Soluble Interacellular Adhesion Molecule type 1. Timepoint: Twenty four hours before the first training session and forty eight hours after the last training session at the end of 10 weeks of intervention. Method of measurement: Serum Blood Sampling, Special Kits.;Monocyte Chemotactic Protein type 1. Timepoint: Twenty four hours before the first training session and forty eight hours after the last training session at the end of 10 weeks of intervention. Method of measurement: Serum Blood Sampling, Special Kits.	—

Measure

Time frame

Interlukine 10. Timepoint: 24 hours before the first session and 48 hours after the last training session at the end of 10 weeks of intervention. Method of measurement: Serum Blood Sampling, Special Kits.;Soluble Interacellular Adhesion Molecule type 1. Timepoint: Twenty four hours before the first training session and forty eight hours after the last training session at the end of 10 weeks of intervention. Method of measurement: Serum Blood Sampling, Special Kits.;Monocyte Chemotactic Protein type 1. Timepoint: Twenty four hours before the first training session and forty eight hours after the last training session at the end of 10 weeks of intervention. Method of measurement: Serum Blood Sampling, Special Kits.

—

Secondary

Measure	Time frame
Blood Pressure. Timepoint: Twenty four hours before the first training session and forty eight hours after last trainnig session at the end of 10 weeks of intervantion. Method of measurement: Rishter Blood Pressure Barometer, milimeter Hg.;Body Fat Percentage. Timepoint: Twenty four hours before the first training session and forty eight hours after last trainnig session at the end of 10 weeks of intervantion. Method of measurement: Yagami Caliper made in Japan.;Vo2max (Maximal Oxygen Consumption). Timepoint: Twenty four hours before the first training session and forty eight hours after last trainnig session at the end of 10 weeks of intervantion. Method of measurement: Bruce test on treadmill.;Cardiac structural and functional variables. Timepoint: Twenty four hours before the first training session and forty eight hours after last trainnig session at the end of 10 weeks of intervantion. Method of measurement: Heart Echocardiographic System.;Lipid Profile. Timepoint: Twenty four hours before the first training session and forty eight hours after last trainnig session at the end of 10 weeks of intervantion. Method of measurement: Serum Blood Sampling.	—

Measure

Time frame

Blood Pressure. Timepoint: Twenty four hours before the first training session and forty eight hours after last trainnig session at the end of 10 weeks of intervantion. Method of measurement: Rishter Blood Pressure Barometer, milimeter Hg.;Body Fat Percentage. Timepoint: Twenty four hours before the first training session and forty eight hours after last trainnig session at the end of 10 weeks of intervantion. Method of measurement: Yagami Caliper made in Japan.;Vo2max (Maximal Oxygen Consumption). Timepoint: Twenty four hours before the first training session and forty eight hours after last trainnig session at the end of 10 weeks of intervantion. Method of measurement: Bruce test on treadmill.;Cardiac structural and functional variables. Timepoint: Twenty four hours before the first training session and forty eight hours after last trainnig session at the end of 10 weeks of intervantion. Method of measurement: Heart Echocardiographic System.;Lipid Profile. Timepoint: Twenty four hours before the first training session and forty eight hours after last trainnig session at the end of 10 weeks of intervantion. Method of measurement: Serum Blood Sampling.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShila Nayebifar

Birjand University

shila_neyebi@yahoo.com+98 56 3223 8192

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026